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Introduction
Over the centuries, 2 well-known mycobacterial species,
namely, Mycobacterium tuberculosis and M. leprae have
been the known causes of immense human suffering.
Many other mycobacteria are ubiquitous in the envi-
ronment with low virulence, but can be opportunistic
and at times deadly pathogens. They are referred to 
as atypical mycobacteria, mycobacteria other than tu-
berculosis, or nontuberculous mycobacteria (NTM).
Among the more than 90 known species of NTM,
about 1 third have been associated with human diseases.
Today, the prevalence of NTM infection is increasing
worldwide. It is partly explained by the increase in the
number of immunocompromised individuals, such as
those suffering from acquired immunodeficiency syn-
drome, and is also due to an increasing awareness 
of NTM as human pathogens and improvements in
methods of mycobacterial culture. Infection has been
well documented to cause glomerulonephritis, with
Streptococcus being the most common pathogen and
predominantly affecting children. The pattern of the
disease has changed over recent decades. Not only
Streptococcus but also other bacterial, viral, fungal and
parasitic infections can trigger the disease in both chil-
dren and adults. Glomerulonephritis caused by tuber-
culosis infection has rarely been reported in the
literature.1–6 To our knowledge, the association of
NTM infection with glomerulonephritis has not been
described before. Herein, we report a case of acute
diffuse proliferative glomerulonephritis with the char-
acteristics of infection-related glomerulonephritis in
which M. avium was the most possible causal pathogen.
Case Report
A 72-year-old woman was admitted with a 2-week
history of cough productive of yellowish, occasionally
blood-streaked sputum. She had also noticed pro-
found malaise, decreased appetite and a weight loss of
5 kg within this time period. There was no complaint
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of fever, epistaxis, or arthralgia. She had been diag-
nosed to have NTM pulmonary disease approximately
5 years before and had received a 12-month course of
antituberculous therapy. Her past medical history was
otherwise unremarkable.
On admission, physical examination showed a body
temperature of 36.5°C, regular pulse rate of 92 beats/
minute, respiratory rate of 18 breaths/minute, and
blood pressure of 128/76 mmHg. Head and neck
examinations were unremarkable. Chest auscultation
revealed diffuse crackles over bilateral lung fields.
Examinations of the heart and abdomen were normal.
She had mild lower extremity pitting edema (+). No skin
lesion was found. A chest X-ray demonstrated inter-
stitial infiltration over bilateral lung fields and fibrous
change of the right upper lung. Laboratory investiga-
tions showed hemoglobin 9.5 g/dL, white blood cell
count 15,400/µL, and platelet count 256,000/µL.
A blood chemistry panel showed urea nitrogen 32mg/
dL, creatinine 2.2mg/dL, sodium 136mmol/L, potas-
sium 3.8mmol/L, calcium 8.1mg/dL, glucose 93mg/
dL, uric acid 8.4 mg/dL, albumin 3.0 g/dL, and glob-
ulin 3.2 g/dL. Urinalysis revealed occult blood (++++)
and protein (++), with numerous red blood cells and
35–40 white blood cells per high-power field in the
urinary sediment. Daily urinary protein excretion was
1.9g. Renal ultrasonography showed normal-sized kid-
neys with increased parenchymal echogenicity sugges-
tive of acute renal parenchymal disease. Owing to acute
renal failure and urinalysis findings suggestive of glo-
merulonephritis, rapidly progressive glomerulonephritis
(RPGN) was highly suspected. Serologic studies showed
negative findings for antinuclear antibody, antibase-
ment membrane antibody, antineutrophil cytoplasmic
antibody, hepatitis B surface antigen, hepatitis C anti-
body, and human immunodeficiency virus antibody.
Antistreptolysin O titer was <200IU/mL. Serum com-
plement levels were normal. Rheumatoid factor was
negative.
Kidney biopsy showed diffuse proliferative glomeru-
lonephritis, with cellular crescents affecting 12 of the
25 examined glomeruli (Figure 1). The glomeruli
displayed endocapillary hypercellularity with capillaries
full of neutrophils. No thickening or double contouring
of capillary loop was seen by periodic acid-Schiff or
periodic acid-methenamine silver stain. Mild interstitial
infiltrate of inflammatory cells was noted. Interstitial
fibrosis and tubular atrophy were present only focally
and minimally. No glomerular tuft necrosis or vasculitis
was seen. Immunofluorescent studies showed granular
staining for IgG (++), IgM (+), C3 (+++), and C1q (+)
along the mesangium and capillary loops (Figure 2).
There was no IgA deposition. Subendothelial and
mesangial electron-dense deposits were noted on elec-
tron microscopy (Figure 3). No subepithelial hump-like
deposit was found. There was no evidence of cryoglob-
ulin deposit.
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Figure 1. Renal biopsy showing diffuse endocapillary proliferative
glomerulonephritis with cellular crescent formation (arrows)
(hematoxylin & eosin, 100×).
Figure 2. Immunofluorescence showing strong granular deposits
of C3 in the glomerular basement membrane and mesangium.
Figure 3. Electron microscopy showing electron-dense deposits
in the subendothelial region (arrows).
Because of histologic resemblance to infection-
related glomerulonephritis, a comprehensive workup
for infection was performed. Echocardiography showed
no evidence of infective endocarditis. Bronchoscopy
revealed no endobronchial lesion. Sputum, blood and
urine bacterial cultures were negative. However, sputum
smears for acid-fast stain were positive. Furthermore,
mycobacterial cultures of the sputum specimens col-
lected by either spontaneous expectoration or bron-
choscopic wash repeatedly yielded M. avium. To clarify
the lung lesions, a thoracoscopic lung biopsy was per-
formed. The specimens demonstrated dilated alveoli full
of mucus, macrophages, and leukocytes. The alveolar
septum was widened by lymphoid aggregation, fibrosis,
and smooth muscle cell proliferation. No alveolar capil-
laritis or granuloma was found. NTM pulmonary disease
was further confirmed when the mycobacterial culture
of the lung biopsy specimens also grew M. avium.
Antituberculous agents comprising rifampicin, iso-
niazide and ethambutol, in combination with clar-
ithromycin were administered for the treatment of
pulmonary NTM infection. Pulmonary symptoms
promptly responded to the treatments. Repeated spu-
tum smears for acid-fast stain and mycobacterial cul-
tures became negative 1 month later. Follow-up chest
X-ray also showed resolution of the pulmonary infil-
trates. Furthermore, renal function steadily improved,
with serum creatinine level falling to 1.1 mg/dL 
3 months after the initiation of anti-NTM therapy.
Discussion
The combination of acute glomerulonephritis, as man-
ifested by hematuria and renal insufficiency, and pul-
monary hemorrhage, as manifested by hemoptysis and
pulmonary infiltrates, is characteristic of pulmonary–
renal syndrome. However, these manifestations can be
seen in acute glomerulonephritis that is complicated
by other pulmonary disorders such as pulmonary edema,
pulmonary embolism, or pulmonary infection. There
is no doubt that it is important to exclude pulmonary
infectious processes before starting immunosuppressive
therapy when pulmonary–renal syndrome is suspected.
However, definite diagnosis of pulmonary NTM in-
fection remains difficult. First, NTM requires special
media and growth conditions. Secondly, the diagnosis
of pulmonary NTM infection is complicated by the
variability in clinical and radiologic manifestations and
the frequent presence of significant prior pulmonary
disease. Finally, in contrast to M. tuberculosis, NTM
are ubiquitous in the environment. Isolation of NTM
from the sputum may represent harmless colonization
of the respiratory tract and does not constitute proof
of the existence of pulmonary NTM infection. In an
attempt to address these difficulties, the American
Thoracic Society has established specific criteria that
emphasize compatible clinical symptoms/signs, reason-
able exclusion of other disease and characteristic imaging
findings such as persistent (>2 months) or progressive
pulmonary infiltrates. Bacteriologic criteria include
positive cultures of at least 3 sputum/bronchial wash
samples within 1 year or any growth from bronchopul-
monary tissue biopsy.7 In our patient, the clinical, radi-
ographic and bacteriologic criteria were all satisfied and
indicated NTM pulmonary disease.
Although the potential virulence of NTM has been
increasingly recognized in humans, NTM infection-
related glomerulonephritis has not yet been described.
Nguyen et al reported a patient with RPGN who devel-
oped severe lower gastrointestinal bleeding 2 weeks
after initiation of aggressive immunosuppressive treat-
ments and was diagnosed to have ulcerative colitis
due to infection with M. avium.8 The intestinal bleed-
ing stopped promptly after administration of anti-NTM
therapy. However, the renal function did not recover,
and the patient was maintained on hemodialysis. The
report emphasized an aggravation of gastrointestinal
NTM infection after immunosuppressive therapy but
did not address the association of NTM infection with
RPGN. In our case, arguments may arise as to whether
the RPGN was an independent disease or was causally
associated with NTM infection. In light of several
observations, we strongly considered that NTM infec-
tion was responsible for the development of RPGN.
First, the kidney biopsy revealed diffuse endocapillary
proliferation with neutrophil exudates as a character-
istic of infection-related glomerulonephritis. Although
subepithelial hump-like deposits were not seen in our
case, they are often but not always found in cases of
infection-associated glomerulonephritis. Secondly, im-
munofluorescence studies showed a granular glomerular
labeling pattern indicative of immune complex-mediated
glomerulonephritis. In the absence of other discernible
causes such as a variety of primary glomerulonephritis,
systemic lupus erythematosus, Henoch-Schönlein pur-
pura, and mixed cryoblobulinemia, infection-related
glomerulonephritis was the most possible clinico-
pathologic diagnosis. Most importantly, recovery of
renal function after treatment of NTM infection fur-
ther suggested a causal relationship between NTM
infection and RPGN. As a result, our case fulfills the
following diagnostic criteria for infection-related glo-
merulonephritis proposed by Montseny et al: (1) evi-
dence of infection preceding the glomerulonephritis;
(2) close temporal relationship between the infection
J Chin Med Assoc • September 2007 • Vol 70 • No 9398
S.J. Chen, et al
J Chin Med Assoc • September 2007 • Vol 70 • No 9 399
Glomerulonephritis and nontuberculous mycobacteria
and glomerulonephritis; (3) glomerular change consis-
tent with an infectious glomerulonephritis; (4) absence
of systemic disease that may cause the glomerulonephri-
tis; (5) exclude IgA nephropathy.9
When comparing with tuberculosis-associated
glomerulonephritis, the glomerular changes with 
predominantly diffuse endocapillary proliferation
observed in our case are nonspecific. On the contrary,
tuberculosis-associated glomerulonephritis has more
specific glomerular changes, and membranoprolifera-
tive glomerulonephritis and IgA nephropathy are the
2 most common histologic findings.1–6
This case also presented a therapeutic dilemma
regarding the use of immunosuppressive agents. Because
of the generally grave prognosis of RPGN and the
known usefulness of immunosuppressive agents in other
types of RPGN, corticosteroids, cytotoxic agents, and
plasmapheresis, alone or in combination, have been
tried in infection-related RPGN.10–15 Although the
limited evidence supports the use of immunosuppres-
sive agents in this setting, serious consideration must
be given to the fact that renal disease might respond
to antimicrobial therapy alone. Furthermore, the risk
of overwhelming underlying infection precipitated by
immunosuppression might abrogate the benefit for
renal function.
In conclusion, RPGN could be associated with M.
avium infection. Although the prognosis of RPGN 
is generally thought to be poor, our case showed a
favorable prognosis when anti-NTM therapy was
administered in a timely manner. The natural history
of infection-related glomerulonephritis perhaps con-
tributed to the excellent outcome.
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